Bend Research & Merck Sign License Agreement

Under the agreement, Oregon-based Bend Research will provide Merck with access to its proprietary spray dried dispersion (SDD) technology.

US drug-formulation development and manufacturing company Bend Research has inked a license pact with Merck, through a subsidiary.

Under the agreement, Oregon-based Bend Research will provide Merck with access to its proprietary spray dried dispersion (SDD) technology.

Bend Research may also give Merck access to other drug-delivery platforms and intellectual property, including modified-release technologies and drug-discovery formulation tools.

The two firms will use their scientific and engineering capabilities to solve complex formulation and process-development problems with a view to transferring these solutions to a cGMP environment.